|
🐜
|
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
23 auth.
T. Karikari,
T. Pascoal,
N. Ashton,
S. Janelidze,
A. Benedet,
Juan Lantero Rodriguez,
M. Chamoun,
Mélissa Savard,
M. Kang,
J. Therriault,
...
M. Schöll,
G. Massarweh,
J. Soucy,
K. Höglund,
G. Brinkmalm,
N. Mattsson,
S. Palmqvist,
S. Gauthier,
E. Stomrud,
H. Zetterberg,
O. Hansson,
P. Rosa-Neto,
K. Blennow
|
9 |
2020 |
9
🐜
|
|
🐬
|
Commentary: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
T. Karikari,
Augustina Charway-Felli,
K. Höglund,
K. Blennow,
H. Zetterberg
|
9 |
2018 |
9
🐬
|
|
🐜
|
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders
21 auth.
B. Olsson,
E. Portelius,
N. Cullen,
Å. Sandelius,
H. Zetterberg,
U. Andreasson,
K. Höglund,
D. Irwin,
M. Grossman,
D. Weintraub,
...
A. Chen-Plotkin,
D. Wolk,
L. McCluskey,
L. Elman,
L. Shaw,
J. Toledo,
Jennifer D. McBride,
Pilar Hernandez-Con,
V. Lee,
J. Trojanowski,
K. Blennow
|
7 |
2019 |
7
🐜
|
|
🐜
|
Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
21 auth.
E. Portelius,
B. Olsson,
K. Höglund,
N. Cullen,
Hlin Kvartsberg,
U. Andreasson,
H. Zetterberg,
Å. Sandelius,
L. Shaw,
V. Lee,
...
D. Irwin,
M. Grossman,
D. Weintraub,
A. Chen-Plotkin,
D. Wolk,
L. McCluskey,
L. Elman,
Jennifer D. McBride,
J. Toledo,
J. Trojanowski,
K. Blennow
|
7 |
2018 |
7
🐜
|
|
🐜
|
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
12 auth.
N. Ashton,
A. Leuzy,
Y. Lim,
C. Troakes,
T. Hortobágyi,
K. Höglund,
...
D. Aarsland,
S. Lovestone,
M. Schöll,
K. Blennow,
H. Zetterberg,
Abdul Hye
|
7 |
2019 |
7
🐜
|
|
🐜
|
Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia
12 auth.
E. Bereczki,
P. Francis,
D. Howlett,
J. Pereira,
K. Höglund,
A. Bogstedt,
...
A. Cedazo-Mínguez,
Jean-Ha Baek,
T. Hortobágyi,
J. Attems,
C. Ballard,
D. Aarsland
|
7 |
2016 |
7
🐜
|
|
🐜
|
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation
11 auth.
L. Gaetani,
K. Höglund,
L. Parnetti,
Fani Pujol-Calderón,
Bruno Becker,
P. Eusebi,
...
P. Sarchielli,
P. Calabresi,
M. Di Filippo,
H. Zetterberg,
K. Blennow
|
7 |
2018 |
7
🐜
|
|
🐜
|
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
17 auth.
N. Ashton,
Abdul Hye,
A. Rajkumar,
A. Leuzy,
S. Snowden,
M. Suárez-Calvet,
T. Karikari,
M. Schöll,
R. La Joie,
G. Rabinovici,
...
K. Höglund,
C. Ballard,
T. Hortobágyi,
P. Svenningsson,
K. Blennow,
H. Zetterberg,
D. Aarsland
|
7 |
2020 |
7
🐜
|
|
🐢
|
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
16 auth.
C. Cicognola,
G. Brinkmalm,
Jessica Wahlgren,
E. Portelius,
J. Gobom,
N. Cullen,
O. Hansson,
L. Parnetti,
R. Constantinescu,
Kristin R. Wildsmith,
...
Hsu-hsin Chen,
T. Beach,
T. Lashley,
H. Zetterberg,
K. Blennow,
K. Höglund
|
7 |
2018 |
7
🐢
|
|
🐜
|
Marked increase of β-amyloid(1–42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury
8 auth.
Annika Olsson,
L. Csajbók,
M. Öst,
K. Höglund,
K. Nylén,
L. Rosengren,
...
B. Nellgård,
K. Blennow
|
6 |
2004 |
6
🐜
|
|
🐜
|
Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia.
13 auth.
B. Olsson,
Joakim Hertze,
Ronald Lautner,
H. Zetterberg,
K. Nägga,
K. Höglund,
H. Basun,
P. Annas,
L. Lannfelt,
N. Andreasen,
...
L. Minthon,
K. Blennow,
O. Hansson
|
6 |
2012 |
6
🐜
|
